Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

U.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...

U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic investment as industry-targeted tariffs loom. This 470 ...

Merck is investing $1 billion to build a ... efforts to stimulate economic growth in the U.S., allowing for the domestic production and distribution of medicines and vaccines to patients here ...

Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Merck Animal Health Announces $895 Million ... and Gilead have recently announced additional investments to boost domestic production amid U.S. President Donald Trump's tariff policies.